Renaissance Technologies - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,961
+133.3%
311,400
+158.2%
0.01%
+250.0%
Q2 2023$1,698
-52.5%
120,600
-47.9%
0.00%
-60.0%
Q1 2023$3,574
+140.3%
231,318
+155.0%
0.01%
+150.0%
Q4 2022$1,487
-99.9%
90,700
+2.0%
0.00%
+100.0%
Q2 2022$1,169,000
-1.2%
88,900
+155.5%
0.00%
-50.0%
Q3 2021$1,183,000
-93.1%
34,800
-91.7%
0.00%
-88.2%
Q1 2020$17,234,000
+29.0%
418,600
+95.1%
0.02%
+70.0%
Q4 2019$13,357,000
+173.9%
214,600
+49.3%
0.01%
+150.0%
Q3 2019$4,877,000143,7000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders